Inclusion and Exclusion Criteria
The criteria for inclusion in the study were as follows: patients with
elevated prostate specific antigen (PSA) level and/or anormal findings
in digital rectal examination. Patients with diagnosed a diesease of
urinary tract infections, coagulopathies, patients who have had surgery
in the past year or patients who received only 5-alfa reductase
inhibitory treatment or as a combination therapy and patients with
inadequate data were also excluded from the study.